![Levon Khachaturyan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Levon Khachaturyan
Direttore/Membro del Consiglio presso Inflamalps SA
Provenienza dei contatti di primo grado di Levon Khachaturyan
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Inflamalps SA
![]() Inflamalps SA Pharmaceuticals: MajorHealth Technology Inflamalps SA operates as a biopharmaceutical company. The firm focuses on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology. The company was founded by Charles Woler, Vincent Mutel and Philippe Meuwly in August 2012 and is headquartered in Monthey, Switzerlands.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Levon Khachaturyan tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Basel - SpA
![]() Basel - SpA MiscellaneousMiscellaneous Part of Smith & Nephew plc, Basel SpA is an Italian company that specializes in medicinal chemicals and botanical products. The company is based in Ravenna, Italy. Basel was acquired by Smith & Nephew plc on April 01, 1995 for $4.80 million. | Miscellaneous | Corporate Officer/Principal | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Founder | |
University of Paris Jussieu | College/University | Doctorate Degree | |
CRI Worldwide LLC
![]() CRI Worldwide LLC Miscellaneous Commercial ServicesCommercial Services CRI Worldwide LLC engages in the provision of inpatient and outpatient clinical research services. It specializes in inpatient and outpatient clinical trials ranging from phase I to IV focusing on pediatrics, adolescents, adults, and elderly in the areas of acute and chronic pain, attention deficit hyperactivity disorder, Alzheimer’s disease, atypical depression, back pain, bipolar disorder, cancer pain, diabetes, epilepsy, fibromyalgia, general anxiety disorder, hepatitis, major depressive disorder, manic depression, migraines/headaches, mild cognitive impairment. The company was founded by Howard A. Hassman in 2000 and is headquartered in Mt. Laurel, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Metys Pharmaceuticals AG
![]() Metys Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Part of Novaremed AG, Metys Pharmaceuticals AG is a pharmaceutical company based in Basel, Switzerland. The Swiss company specializes in developing dimiracetam for the prevention of chemotherapy-induced neuropathic pain. The company was founded by Michael Scherz, who has been the CEO since incorporation. Metys Pharmaceuticals was acquired by Novaremed AG on September 07, 2021. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Svizzera | 4 |
Italia | 2 |
Regno Unito | 2 |
Francia | 2 |
Stati Uniti | 2 |
Settori
Health Technology | 5 |
Miscellaneous | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 6 |
Founder | 4 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
Vincent Mutel | 9 |
Philippe Meuwly | 1 |
Oleg Sharonov | 1 |
- Borsa valori
- Insiders
- Levon Khachaturyan
- Connessioni Società